Aptadel Therapeutics

aliveseed
seed
Stage
2019
Founded
1
Investors

About

Aptadel Therapeutics is a biotechnology company developing innovative aptamer-based therapies for cancer. They focus on the discovery and development of these novel treatments.

Explore Aptadel Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.